W. Witt

584 total citations
22 papers, 430 citations indexed

About

W. Witt is a scholar working on Pulmonary and Respiratory Medicine, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, W. Witt has authored 22 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 6 papers in Pharmacology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in W. Witt's work include Blood properties and coagulation (7 papers), Analytical Methods in Pharmaceuticals (6 papers) and Venous Thromboembolism Diagnosis and Management (6 papers). W. Witt is often cited by papers focused on Blood properties and coagulation (7 papers), Analytical Methods in Pharmaceuticals (6 papers) and Venous Thromboembolism Diagnosis and Management (6 papers). W. Witt collaborates with scholars based in Germany, United Kingdom and United States. W. Witt's co-authors include Peter Donner, S Stürzebecher, Peter Bringmann, Linda Cashion, E. Schillinger, Wolf‐Dieter Schleuning, Werner Skuballa, Michael S. Hildebrand, Bettina Müller and Martin Haberey and has published in prestigious journals such as Circulation, Blood and Radiology.

In The Last Decade

W. Witt

21 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Witt Germany 12 130 109 103 90 74 22 430
MA Guccione Canada 12 129 1.0× 110 1.0× 175 1.7× 30 0.3× 273 3.7× 19 544
Giuseppe Dell’Elba Italy 11 55 0.4× 102 0.9× 106 1.0× 25 0.3× 150 2.0× 18 483
Hans‐Joachim Reimers Canada 8 133 1.0× 101 0.9× 132 1.3× 22 0.2× 258 3.5× 17 561
Takuo Sato Japan 8 45 0.3× 129 1.2× 41 0.4× 27 0.3× 60 0.8× 15 413
A. Nakao Japan 12 58 0.4× 180 1.7× 34 0.3× 33 0.4× 21 0.3× 20 455
Alf‐Åge R. Pettersen Norway 13 28 0.2× 112 1.0× 233 2.3× 37 0.4× 72 1.0× 22 485
Sergio Alonso‐Orgaz Spain 11 42 0.3× 138 1.3× 154 1.5× 67 0.7× 34 0.5× 18 389
Sho Isogai Japan 11 153 1.2× 113 1.0× 46 0.4× 72 0.8× 18 0.2× 24 551
Thomas M. Coffman United States 8 34 0.3× 140 1.3× 131 1.3× 15 0.2× 84 1.1× 9 572
Bart J. van Vlijmen Netherlands 8 33 0.3× 155 1.4× 80 0.8× 63 0.7× 146 2.0× 9 527

Countries citing papers authored by W. Witt

Since Specialization
Citations

This map shows the geographic impact of W. Witt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Witt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Witt more than expected).

Fields of papers citing papers by W. Witt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Witt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Witt. The network helps show where W. Witt may publish in the future.

Co-authorship network of co-authors of W. Witt

This figure shows the co-authorship network connecting the top 25 collaborators of W. Witt. A scholar is included among the top collaborators of W. Witt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Witt. W. Witt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woodring, J H, et al.. (2015). Unilateral Pulmonary Edema. Contemporary Diagnostic Radiology. 38(18). 6–6.
2.
Gulba, Dietrich C., Michael Praus, & W. Witt. (1995). DSPA alpha — Properties of the plasminogen activators of the vampire bat Desmodus rotundus. Fibrinolysis and Proteolysis. 9. 91–96. 13 indexed citations
3.
Morser, John, et al.. (1994). A new animal model of venous thrombosis in rats with low flow conditions in the venous blood stream. Blood Coagulation & Fibrinolysis. 5(2). 243–248. 7 indexed citations
4.
5.
6.
Schleuning, Wolf‐Dieter, Alejandro Alagón, Werner Boidol, et al.. (1992). Plasmhogen Activators from the Saliva of Desmodus rotundus (Common Vampire Bat): Unique Fibrin Specificity. Annals of the New York Academy of Sciences. 667(1). 395–403. 34 indexed citations
7.
8.
Schillinger, E., et al.. (1991). Effects of prostacyclin analogues in in vivo tumor models.. PubMed. 21B. 901–8. 10 indexed citations
9.
Stürzebecher, S & W. Witt. (1988). The PGI2-analogue iloprost and the TXA2-receptor antagonist sulotroban synergistically inhibit TXA2-dependent platelet activation. Prostaglandins. 36(6). 751–760. 11 indexed citations
10.
11.
Witt, W., et al.. (1988). 369 Stimulation of fibrinolytic activity in rats by prostacyclin (PGI2)-analogues (Iloprost; cicarprost) and PGI2-releaser (defibrotide). Fibrinolysis and Proteolysis. 2. 157–157. 1 indexed citations
12.
Müller, Bettina, et al.. (1988). Adherence of leucocytes to electrically damaged venules in vivo. Effects of iloprost, PGE1, indomethacin, forskolin, BW 755 C, sulotroban, hirudin, and thrombocytopenia.. PubMed. 1(1). 13–7. 23 indexed citations
13.
Stürzebecher, S, et al.. (1988). Potential therapeutic mechanisms of stable prostacyclin (PGI2)-mimetics in severe peripheral vascular disease.. PubMed. 47(10-11). S40–4. 10 indexed citations
14.
Stürzebecher, S, et al.. (1988). Potential therapeutic mechanisms of stable prostacyclin (PGI2)-mimetics in severe peripheral vascular disease. Pharmacological Research Communications. 20. 259–259. 4 indexed citations
15.
Witt, W., et al.. (1987). Action of the stable prostacyclin analogue iloprost on microvascular tone and -permeability in the hamster cheek pouch. Prostaglandins Leukotrienes and Medicine. 29(2-3). 187–198. 40 indexed citations
16.
Witt, W., et al.. (1987). Antithrombotic profile of iloprost in experimental models of in vivo platelet aggregation and thrombosis.. PubMed. 17A. 279–84. 16 indexed citations
17.
Stürzebecher, S, Martin Haberey, E. Schillinger, et al.. (1986). Pharmacological profile of a novel carbacyclin derivative with high metabolic stability and oral activity in the rat. Prostaglandins. 31(1). 95–109. 63 indexed citations
18.
Mueller, Bruce A., et al.. (1986). Limitation of myocardial unperfused area and necrotic zone 24 hours and 7 days after coronary artery ligation in rats by the stable prostacyclin analogue iloprost. Prostaglandins Leukotrienes and Medicine. 21(3). 331–340. 3 indexed citations
19.
Smith, Clyde W., et al.. (1982). Evaluation of digital venous angiography for the diagnosis of renovascular hypertension.. Radiology. 144(1). 51–54. 35 indexed citations
20.
Witt, W.. (1979). Lexikon der Kartographie. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by MA Guccione Breakdown of academic impact, for papers by Giuseppe Dell’Elba Breakdown of academic impact, for papers by Hans‐Joachim Reimers Breakdown of academic impact, for papers by Takuo Sato Breakdown of academic impact, for papers by A. Nakao Breakdown of academic impact, for papers by Alf‐Åge R. Pettersen Breakdown of academic impact, for papers by Sergio Alonso‐Orgaz Breakdown of academic impact, for papers by Sho Isogai Breakdown of academic impact, for papers by Thomas M. Coffman Breakdown of academic impact, for papers by Bart J. van Vlijmen
Rankless by CCL
2026